Brain volumes and regional cerebral blood flow in carriers of the Swedish alzheimer amyloid protein mutation

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 1, 1998, Pages 49-53

  Julin, Per ^a,b   Almkvist, Ove ^a   Basun, Hans ^a   Lannfelt, Lars ^a   Svensson, Leif ^b   Winblad, Bengt ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid precursor protein; Magnetic resonance imaging (MRI); Mutation; Single photon emission computed tomography (SPECT)

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 0032465889     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199803000-00008     Document Type: Article

References (34)

1. Almkvist O, Basun H, Wahlund L-O, Lannfelt L. Cognitive functions of family members with and without the APP 670/671 mutation. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds. Research advances in Alzheimer's disease and related disorders. Chichester, U.K.: John Wiley & Sons Ltd., 1995:251-9.
2. Almkvist O, Bäckman L. Detection and staging of early clinical dementia. Acta Neurol Scand 1993a;88:10-5.
3. Almkvist O, Bäckman L. Progression in Alzheimer's disease: sequencing of neuropsychological decline. Int J Geriatr Psychiatry 1993b;8:755-63.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., rev. Washington, DC: APA, 1987.
5. Axelman K, Basun H, Winblad B, Lannfelt L. A clinical and genealogical investigation of a large Swedish family with a codon 670/671 amyloid precursor protein mutation. Arch Neurol 1994;51:1193-7.
6. Braak H, Braak H. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-56.
7. Bäckman L, Forsell Y. Episodic memory functioning in a community-based sample of very old adults with major depression: utilization of cognitive support. J Abnorm Psychol 1994;103:361-70.
8. Cuenod CA, Denys A, Michot JL, et al. Amygdala atrophy in Alzheimer's disease: an in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-5.
9. de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiol 1993;14:897-906.
10. Dewan MJ, Gupta S. Toward a definite diagnosis of Alzheimer's disease. Compr Psychiatry 1992;33:282-90.
11. Fukuyama H, Harada K, Yamauchi H, et al. Coronal reconstruction of glucose metabolism in Alzheimer's disease. J Neurol Sci 1991;106:128-34.
12. Grady CL, Haxby JV, Horwitz B, et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988;10:576-96.
13. Ikeda M, Tanabe H, Nakagawa Y, et al. MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology 1994;36:7-10.
14. Jack CJ, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-8.
15. Jagust WJ, Eberling JL. MRI, CT, SPECT, PET: their use in diagnosing dementia. Geriatrics 1991;46:28-35.
16. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-4.
17. Julin P, Lindqvist J, Slomka P, Svensson L, Wahlund L-O. MRI-guided SPECT measurements of medial temporal blood flow reduction in Alzheimer's disease. J Nucl Med 1997;38:914-9.
18. Julin P, Melin T, Andersen C, Isberg B, Svensson L, Wahlund L-O. Interactive 3-dimentional brain volumetry using MP-RAGE magnetic resonance imaging. Psychiatr Res Neuroimaging (in press).
19. Kennedy A, Rossor M, Frackowiak R. Positron emission tomography in familial Alzheimer's disease. Alzheimer Dis Assoc Disord 1995;9:17-20.
20. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-54.
21. Labbe C, Froment JC, Kennedy A, Ashburner J, Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord 1996;10:141-70.
22. Lannfelt L, Bogdanovich N, Appelgren H, Axelman K, Lilius L, Hansson G. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 1994;168:254-6.
23. 99mTc-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8:S13-22.
24. Lezak M. Neuropsychological assessment, 2nd ed. New York: Oxford University Press, 1983.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
26. Milner B. Interhemispheric differences in location of psychological processes in man. Br Med Bull 1971;27:272-7.
27. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at terminus of the beta-amyloid. Nature Genet 1992;1:345-7.
28. Pearlson G, Harris G, Powers R, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-8.
29. Postiglione A, Lassen NA, Holman BL. Cerebral blood flow in patients with dementia of Alzheimer's type. Aging Clin Exp Res 1993;5:19-26.
30. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-72.
31. Seab JP, Jagust WJ, Wong ST, Roos MS, Reed BR, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-8.
32. Wahlund LO, Andersson-Lundman G, Basun H, et al. Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magn Reson Imaging 1993;11:169-74.
33. Wechsler D. Adult Intelligence Scale Revised: manual. New York: The Psychological Corporation, 1981.
34. Weinstein H, Scheltens P, Hijdra A, van Royen EA. Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography. Clin Neurol Neurosurg 1993;95:81-91.